Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04525690 · ClinicalTrials.gov registry record · NA
Improving Inpatient Screening for Hepatitis C
A NA study of Hepatitis C, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 7,634
- Enrollment target
- 1
- Study location
NCT04525690: Completed NA study of Hepatitis C, sponsored by University of Pennsylvania.
NCT04525690 is a NA study of Hepatitis C that has completed, run by University of Pennsylvania. The registered enrollment target is 7,634 participants, above the 1,818-participant average among 106 other Hepatitis C trials with a reported enrollment target (320% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04525690, a NA study of Hepatitis C, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 7,634 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will use a stepped-wedge cluster randomized clinical trial to evaluate a health system initiative to set defaults in the electronic health record admission order set to nudge inpatient hepatitis C (HCV) screening.
Primary Outcome
The change in the percentage of eligible hospitalized patients that receive HCV antibody screening
Conditions Studied
Interventions
- BEHAVIORAL Nudge
Study Locations (1)
Pennsylvania
- Penn Medicine - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,634 participants |
| Start Date | 2020-09-21 |
| Est. Completion | 2021-04-10 |
| Phase | NA |
What the finished NCT04525690 record still lists
NCT04525690 is an interventional study that assigns participants to a tested intervention. Its 7,634 participants enrollment target places it among the larger protocols in the corpus, above the 1,818-participant average among 106 other Hepatitis C trials with a reported enrollment target (320% higher).
The record links to 1 condition, with Hepatitis C appearing as the primary indexed condition, and to 1 intervention - of which Nudge is the first listed.
NCT04525690 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04525690 about?
NCT04525690 is a clinical study titled "Improving Inpatient Screening for Hepatitis C". This study will use a stepped-wedge cluster randomized clinical trial to evaluate a health system initiative to set defaults in the electronic health record admission order set to nudge inpatient hepatitis C (HCV) screening.
What is the current status of trial NCT04525690?
This trial is currently completed. It is a NA study. The enrollment target is 7,634 participants. The study started on 2020-09-21. Estimated completion is 2021-04-10.
What conditions does trial NCT04525690 study?
This clinical trial studies the following conditions: Hepatitis C.
What interventions are being tested in trial NCT04525690?
The interventions under investigation include: Nudge (BEHAVIORAL).
Who is sponsoring clinical trial NCT04525690?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04525690 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis C
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04525690's enrollment target sits among peer trials
7,634 4th of 106 higher than 103 of 106 other Hepatitis C trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hepatitis C trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
DBS TaT in Peer-assisted Telemedicine for Hepatitis C
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
RECRUITING · NA
-
HCV Tappt Adherence Study
RECRUITING · NA
-
Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum
RECRUITING · NA
-
Buprenorphine Integration Research and Community Health
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06560398 · 7,649 participants · NA
Working Through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDER²S)
- NCT03848312 · 7,600 participants · Phase 3
Preventing Alzheimer's With Cognitive Training
- NCT00439049 · 7,500 participants
Substance Abuse Pre-Treatment Screening Study
- NCT04809740 · 7,500 participants · NA
Evaluating the Implementation and Impact of Navigator-delivered ePRO System
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI